Eli Lilly and Company (LLY) Short Interest Ratio & Short Volume

Short interest is the volume of Eli Lilly and Company shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 5,540,000 shares of LLY short. 0.65% of Eli Lilly and Company's shares are currently sold short. Learn More on Eli Lilly and Company's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LLY shares currently have a short interest ratio of 2.0. Learn More on Eli Lilly and Company's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eli Lilly and Company: Oak Hill Wealth Advisors LLC, Simplex Trading LLC, Valeo Financial Advisors LLC, SteelPeak Wealth LLC, Wealth Enhancement Advisory Services LLC, Curated Wealth Partners LLC, Capital CS Group LLC, Tortoise Investment Management LLC, Readystate Asset Management LP, Oxford Financial Group LTD. LLC, Parallax Volatility Advisers L.P., BlueCrest Capital Management Ltd, Citadel Advisors LLC, Point72 Asset Management L.P., Artia Global Partners LP, Cresset Asset Management LLC, Verition Fund Management LLC, Capital Fund Management S.A., PEAK6 Investments LLC, Eisler Capital US LLC, Eisler Capital UK Ltd., Kopernik Global Investors LLC, Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, Mendel Money Management, US Bancorp DE, IMC Chicago LLC, Wells Fargo & Company MN, UBS Group AG, Tortoise Investment Management LLC, Bedel Financial Consulting Inc., BNP Paribas Financial Markets, Monaco Asset Management SAM, Gladius Capital Management LP, CenterStar Asset Management LLC, Concourse Financial Group Securities Inc., Genus Capital Management Inc., Private Advisor Group LLC, Brandywine Oak Private Wealth LLC, XR Securities LLC, Wolverine Asset Management LLC, SpiderRock Advisors LLC, and Valeo Financial Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.65% of Eli Lilly and Company's floating shares are currently sold short.

Eli Lilly and Company saw a increase in short interest in April. As of April 15th, there was short interest totaling 5,540,000 shares, an increase of 2.2% from the previous total of 5,420,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Eli Lilly and Company currently has issued a total of 950,160,000 shares. Some of Eli Lilly and Company's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eli Lilly and Company currently has a public float of 849,820,000 shares.

0.65% of Eli Lilly and Company's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Eli Lilly and Company: Johnson & Johnson (0.69%), Merck & Co., Inc. (0.81%), AbbVie Inc. (0.76%), Novo Nordisk A/S (0.07%), AstraZeneca PLC (0.28%), Novartis AG (0.19%), Abbott Laboratories (0.75%), UnitedHealth Group Incorporated (0.86%), Thermo Fisher Scientific Inc. (0.68%), Pfizer Inc. (1.20%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling LLY is an investing strategy that aims to generate trading profit from Eli Lilly and Company as its price is falling. LLY shares are trading up $8.64 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Eli Lilly and Company occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LLY, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LLY, twice per month. The most recent reporting period available is April, 15 2024.